Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).
Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, Nishimura E, Isshiki T; RESTART Investigators. Kimura T, et al. Among authors: aizawa t. Circulation. 2010 Jul 6;122(1):52-61. doi: 10.1161/CIRCULATIONAHA.109.903955. Epub 2010 Jun 21. Circulation. 2010. PMID: 20566955
Peri-stent contrast staining and very late stent thrombosis after sirolimus-eluting stent implantation: an observation from the RESTART (REgistry of Stent Thrombosis for review And Re-evaluaTion) angiographic substudy.
Kozuma K, Kimura T, Suzuki N, Miyazawa A, Waseda K, Honda Y, Morimoto T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Isshiki T. Kozuma K, et al. Among authors: aizawa t. EuroIntervention. 2013 Nov;9(7):831-40. doi: 10.4244/EIJV9I7A137. EuroIntervention. 2013. PMID: 23410581 Free article. Review.
Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationale.
Nakamura M, Nanto S, Hirayama A, Takayama T, Nishikawa M, Kimura K, Morita S, Aizawa T, Asano R, Matsumaru Y, Hamada C, Isshiki T; OPERA Steering Committee and Investigators. Nakamura M, et al. Among authors: aizawa t. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):368-74. doi: 10.1002/ccd.25282. Epub 2013 Dec 31. Catheter Cardiovasc Interv. 2014. PMID: 24382824 Clinical Trial.
Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential "thromborestenosis" phenomenon.
Oikawa Y, Yajima J, Costa MA, Matsuno S, Akabane M, Funada R, Inaba T, Nakagawa Y, Nakamura M, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Aizawa T. Oikawa Y, et al. Among authors: aizawa t. EuroIntervention. 2010 Aug;6(3):380-7. doi: 10.4244/EIJV6I3A63. EuroIntervention. 2010. PMID: 20884418
1,359 results